Lifecore Biomedical, Inc. LFCR Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Lifecore Biomedical, Inc. (LFCR) reported cash provided by (used in) operating activity, including discontinued operation of $4.7M in Q1 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s cash provided by (used in) operating activity, including discontinued operation?
- Over 2 years (2022 to 2024), Lifecore Biomedical, Inc.'s cash provided by (used in) operating activity, including discontinued operation has grown at a -89.6% compound annual growth rate (CAGR), from -$23.9M to $257K.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.